Researches in colorectal cancer (CRC) have also shown that METTL3 upregulates in the cells and through an m6A-dependent manner and maintains the expression of SRY-box 2 (SOX2) that is a CSC marker. The gene discussed is SOX2; the disease is colorectal carcinoma.